These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27631090)

  • 1. Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion.
    Christensen SM; Dillon LA; Carvalho LP; Passos S; Novais FO; Hughitt VK; Beiting DP; Carvalho EM; Scott P; El-Sayed NM; Mosser DM
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004992. PubMed ID: 27631090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
    Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
    PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular variants of Leishmania (Viannia) braziliensis trigger distinct patterns of cytokines and chemokines expression in golden hamster.
    Rêgo FD; Fradico JRB; Teixeira-Carvalho A; Gontijo CMF
    Mol Immunol; 2019 Feb; 106():36-45. PubMed ID: 30576950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amastin Knockdown in Leishmania braziliensis Affects Parasite-Macrophage Interaction and Results in Impaired Viability of Intracellular Amastigotes.
    de Paiva RM; Grazielle-Silva V; Cardoso MS; Nakagaki BN; Mendonça-Neto RP; Canavaci AM; Souza Melo N; Martinelli PM; Fernandes AP; daRocha WD; Teixeira SM
    PLoS Pathog; 2015 Dec; 11(12):e1005296. PubMed ID: 26641088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis.
    Oliveira PR; Dessein H; Romano A; Cabantous S; de Brito ME; Santoro F; Pitta MG; Pereira V; Pontes-de-Carvalho LC; Rodrigues V; Rafati S; Argiro L; Dessein AJ
    J Immunol; 2015 Mar; 194(6):2664-72. PubMed ID: 25672756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional Analysis of Human Skin Lesions Identifies Tryptophan-2,3-Deoxygenase as a Restriction Factor for Cutaneous
    Rodrigues V; André S; Maksouri H; Mouttaki T; Chiheb S; Riyad M; Akarid K; Estaquier J
    Front Cell Infect Microbiol; 2019; 9():338. PubMed ID: 31637219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
    Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
    Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cytokine Network Balance Influences the Fate of
    Paiva MB; Ribeiro-Romão RP; Resende-Vieira L; Braga-Gomes T; Oliveira MP; Saavedra AF; Silva-Couto L; Albuquerque HG; Moreira OC; Pinto EF; Da-Cruz AM; Gomes-Silva A
    Front Immunol; 2021; 12():656919. PubMed ID: 34276650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
    Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
    Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania amazonensis downregulates macrophage iNOS expression via Histone Deacetylase 1 (HDAC1): a novel parasite evasion mechanism.
    Calegari-Silva TC; Vivarini ÁC; Pereira RMS; Dias-Teixeira KL; Rath CT; Pacheco ASS; Silva GBL; Pinto CAS; Dos Santos JV; Saliba AM; Corbett CEP; de Castro Gomes CM; Fasel N; Lopes UG
    Eur J Immunol; 2018 Jul; 48(7):1188-1198. PubMed ID: 29645094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomics analysis highlights potential ways in human pathogenesis in Leishmania braziliensis infected with the viral endosymbiont LRV1.
    Felipin KP; Paloschi MV; Silva MDS; Ikenohuchi YJ; Santana HM; Setúbal SDS; Rego CMA; Lopes JA; Boeno CN; Serrath SN; De Medeiros EHRT; Pimentel IF; Oliveira AER; Cupolillo E; Cantanhêde LM; Ferreira RGM; Zuliani JP
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012126. PubMed ID: 38743668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
    Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
    Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology.
    Novais FO; Carvalho LP; Passos S; Roos DS; Carvalho EM; Scott P; Beiting DP
    J Invest Dermatol; 2015 Jan; 135(1):94-101. PubMed ID: 25036052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection.
    Almeida L; Silva JA; Andrade VM; Machado P; Jamieson SE; Carvalho EM; Blackwell JM; Castellucci LC
    Infect Genet Evol; 2017 Apr; 49():212-220. PubMed ID: 28119029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage Polarization in the Skin Lesion Caused by Neotropical Species of
    Sandoval Pacheco CM; Araujo Flores GV; Gonzalez K; de Castro Gomes CM; Passero LFD; Tomokane TY; Sosa-Ochoa W; Zúniga C; Calzada J; Saldaña A; Corbett CEP; Silveira FT; Laurenti MD
    J Immunol Res; 2021; 2021():5596876. PubMed ID: 33937417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin in the host response to Leishmania amazonensis.
    Giraud E; Rouault E; Fiette L; Colle JH; Smirlis D; Melanitou E
    BMC Microbiol; 2019 Feb; 19(1):32. PubMed ID: 30736736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual Role of Insulin-Like Growth Factor (IGF)-I in American Tegumentary Leishmaniasis.
    de O Mendes-Aguiar C; Lopes-Siqueira C; Pettito-Assis F; Pereira-Oliveira M; de Oliveira-Neto MP; Pirmez C; Da-Cruz AM; Goto H
    J Immunol Res; 2021; 2021():6657785. PubMed ID: 33860062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histopathologic features of canine tegumentary leishmaniasis and the molecular characterization of Leishmania braziliensis in dogs.
    Lago J; Silva JA; Borja L; Fraga DBM; Schriefer A; Arruda S; Lago E; Carvalho EM; Bacellar O
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007532. PubMed ID: 31310601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.
    Duarte MC; Lage DP; Martins VT; Costa LE; Carvalho AMRS; Ludolf F; Santos TTO; Vale DL; Roatt BM; Menezes-Souza D; Fernandes AP; Tavares CAP; Coelho EAF
    Immunobiology; 2017 Feb; 222(2):251-260. PubMed ID: 27693018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.